This inventor holds 2 USPTO granted patents. Top assignee: Russian-American Institute for New Drug Development. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Moscow, RU (1995)
- Moscow, SU (1995)
Company Filing History:
Years Active: 1995
Title: Tatiana A Voronina: Innovator in Psychotropic Compounds
Introduction
Tatiana A Voronina is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of psychotropic compounds, focusing on substances that enhance learning and memory. With a total of 2 patents, her work is recognized for its potential therapeutic applications.
Latest Patents
Voronina's latest patents include innovative compounds such as biologically active N-acylprolydipeptides. These substances are noted for their antiamnestic properties and psychotropic activity, particularly in facilitating learning and memory. The N-acyl-prolyldipeptides she has developed possess a specific formula that allows for various alkyl and aryl substitutions, enhancing their effectiveness. Another notable patent involves 1,2,3,4-tetrahydropyrrolo-[1,2-a]-pyrazine derivatives, which exhibit anxiolytic activity and are designed to improve mental well-being.
Career Highlights
Tatiana A Voronina is affiliated with the Russian-American Institute for New Drug Development. Her work at this institution has allowed her to explore and develop new drug candidates that address cognitive impairments and anxiety disorders. Her research is characterized by a commitment to advancing the understanding of psychotropic substances.
Collaborations
Voronina has collaborated with notable colleagues in her field, including James A Halikas and Grigori G Rozantsev. These partnerships have contributed to the depth and breadth of her research, fostering innovation in drug development.
Conclusion
Tatiana A Voronina stands out as a key figure in the development of psychotropic compounds that have the potential to improve cognitive functions and mental health. Her contributions to the field are significant and continue to influence research in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile